https://covid19criticalcare.com/wp-content/uploads/2020/06/MATH_ReleaseProtocol_2020-6-16_FLCCC.pdf  Protocol found here

Please notice one of Wisconsin’s own, Pierre Kory, M.D, medical director at the Trauma & Life Support Center and a faculty member in the Division of Allergy, Pulmonary and Critical Care Medicine in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, is a part of FLCCC (Front Line COVID-19 Critical Care Working Group). 

For more:  https://madisonarealymesupportgroup.com/2020/06/02/successful-covid-19-critical-care-stonewalled-by-cdc/

If the MATH+ protocol works with near-100% effectiveness, a vaccine may not even be necessary. The MATH+ protocol gets its name from:

Intravenous Methylprednisolone

High-dose intravenous Ascorbic acid

Plus optional treatments Thiamine, zinc and vitamin D

Full dose low molecular weight Heparin

Kory’s testimony transcript reviews and summarizes the MATH+ protocol, and explains why the timing of the treatment is so important. As explained by Kory, there are two distinct yet overlapping phases of COVID-19 infection.

  1. Phase 1 is the viral replication phase. Typically, patients will only experience mild symptoms, if any, during this phase. At this time, it’s important to focus on antiviral therapies.
  2. In Phase 2, the hyperinflammatory immune response sets in, which can result in organ failures (lungs, brain, heart and kidneys). The MATH+ protocol is designed to treat this active phase, but it needs to be administered early enough.